Jin Lu

449 total citations
38 papers, 222 citations indexed

About

Jin Lu is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Jin Lu has authored 38 papers receiving a total of 222 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Genetics. Recurrent topics in Jin Lu's work include Breast Cancer Treatment Studies (5 papers), Estrogen and related hormone effects (4 papers) and Breast Lesions and Carcinomas (3 papers). Jin Lu is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Estrogen and related hormone effects (4 papers) and Breast Lesions and Carcinomas (3 papers). Jin Lu collaborates with scholars based in China, United Kingdom and United States. Jin Lu's co-authors include Yu Rao, Xia Yao, Cheng Du, Jiong Wu, Zhen Shen, Yujie Ren, Kaili Zhang, Wen Tao Yang, Ta‐Chen Su and Jianchang Gao and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Cell Metabolism.

In The Last Decade

Jin Lu

31 papers receiving 217 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jin Lu China 9 75 54 49 39 22 38 222
Waraporn Chan-on Thailand 9 108 1.4× 61 1.1× 77 1.6× 25 0.6× 14 0.6× 14 238
Qunying Wu China 10 243 3.2× 58 1.1× 100 2.0× 45 1.2× 27 1.2× 15 351
Dong-Jun Lin China 11 277 3.7× 87 1.6× 76 1.6× 24 0.6× 26 1.2× 11 420
Mario Schindeldecker Germany 12 208 2.8× 95 1.8× 74 1.5× 14 0.4× 27 1.2× 31 387
Anca Năstase Romania 9 198 2.6× 88 1.6× 78 1.6× 23 0.6× 66 3.0× 17 309
Jitendra Kumar Kanaujiya India 14 263 3.5× 64 1.2× 49 1.0× 60 1.5× 10 0.5× 20 396
Yen‐Ying Chen Taiwan 9 177 2.4× 63 1.2× 45 0.9× 26 0.7× 39 1.8× 11 317
Lin‐wen Wu China 12 225 3.0× 88 1.6× 82 1.7× 31 0.8× 35 1.6× 18 381
Tammy M. Havener United States 11 184 2.5× 46 0.9× 40 0.8× 28 0.7× 14 0.6× 31 341
Linyi Liu China 14 191 2.5× 72 1.3× 27 0.6× 103 2.6× 21 1.0× 31 395

Countries citing papers authored by Jin Lu

Since Specialization
Citations

This map shows the geographic impact of Jin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Lu more than expected).

Fields of papers citing papers by Jin Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Lu. The network helps show where Jin Lu may publish in the future.

Co-authorship network of co-authors of Jin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Jin Lu. A scholar is included among the top collaborators of Jin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin Lu. Jin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Jin, Anil Kumar Yadav, Shivani Bansal, et al.. (2025). Pyruvate kinase M2 activation reprograms mitochondria in CD8 T cells, enhancing effector functions and efficacy of anti-PD1 therapy. Cell Metabolism. 37(6). 1294–1310.e7. 11 indexed citations
2.
Tai, Youyi, et al.. (2025). Enhanced neuromorphogenesis of neural stem cells via the optimization of physical stimulus-responsive signaling pathways. Stem Cell Research & Therapy. 16(1). 385–385. 1 indexed citations
3.
Lu, Jin, Lin Yang, Jingjing He, et al.. (2025). Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Systemic Lupus Erythematosus via Glucose Metabolism of CD4+T Cells. Stem Cell Reviews and Reports. 21(4). 1013–1033.
5.
Hu, Haochang, Yi Qian, Juan Fang, et al.. (2025). Mechanisms of matrix stiffness affecting calcific aortic valve disease by regulating Piezo1. Atherosclerosis. 411. 120553–120553.
7.
Chen, Yung‐Chang, Hai Hu, Bo Song, et al.. (2024). A phase ib-II study of dabrafenib, trametinib, cetuximab plus irinotecan in patients with BRAF mutant metastatic colorectal cancer: Subgroup analysis and biomarker identification.. Journal of Clinical Oncology. 42(16_suppl). e15581–e15581. 1 indexed citations
9.
Luo, Hui, Jin Lu, Yuxian Bai, et al.. (2024). Final analysis of the randomized phase 3 ESCORT-1st trial: Camrelizumab plus chemotherapy as first-line treatment for advanced or metastatic esophageal squamous cell carcinoma.. Journal of Clinical Oncology. 42(16_suppl). 4055–4055. 1 indexed citations
10.
Xu, Jingya, Wei Chen, Jin Lu, et al.. (2023). Myofiber Baf60c controls muscle regeneration by modulating Dkk3-mediated paracrine signaling. The Journal of Experimental Medicine. 220(9). 16 indexed citations
11.
Yang, Lin, Xiaoping Wang, Jin Lu, et al.. (2023). Efficacy of non-conventional synthetic DMARDs for patients with rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis. RMD Open. 9(4). e003487–e003487. 10 indexed citations
12.
Lu, Jin, et al.. (2022). Efficacy and safety of mesenchymal stem cells in the treatment of systemic sclerosis: a systematic review and meta-analysis. Stem Cell Research & Therapy. 13(1). 118–118. 12 indexed citations
14.
Zhao, Yue, Chenxi Zhao, Jin Lu, et al.. (2019). Sesterterpene MHO7 suppresses breast cancer cells as a novel estrogen receptor degrader. Pharmacological Research. 146. 104294–104294. 24 indexed citations
16.
Du, Cheng, Ming-Hui Dong, Yujie Ren, Jin Lu, & Cheng Xu. (2016). Design, synthesis and antibreast cancer MCF-7 cells biological evaluation of heterocyclic analogs of resveratrol. Journal of Asian Natural Products Research. 19(9). 890–902. 10 indexed citations
17.
Gao, Jianchang, Kaili Zhang, Jin Lu, & Ta‐Chen Su. (2015). Serum matrix metalloproteinases-3 levels in patients with ankylosing spondylitis. Genetics and Molecular Research. 14(4). 17068–17078. 17 indexed citations
18.
Dong, Chuan, Jia Wu, Wen Tao Yang, et al.. (2010). Molecular subtype approximated by quantitative estrogen receptor, progesterone receptor and Her2 can predict the prognosis of breast cancer.. PubMed. 96(1). 103–10. 33 indexed citations
19.
Dong, Chuan, Guangyu Liu, Jiong Wu, et al.. (2009). Neoadjuvant chemotherapy with vinorelbine-containing regimens in elderly patients with locally advanced breast cancer.. PubMed. 28(5B). 3093–7. 3 indexed citations
20.
Hou, Yi, Jiong Wu, Jin Lu, et al.. (2005). [In vitro study of the effects of estrogen receptor beta expression on the biological behavior of a human breast cancer cell line].. PubMed. 27(7). 389–92. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026